Elliott DA - Search Results

1

National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer.

Stensland KD, Caram MEV, Herr DJ, Burns JA, Sparks JB, Elliott DA, Shin C, Morgan TM, Zaslavsky A, Hollenbeck BK, Tsodikov A, Skolarus TA. Stensland KD, et al. Among authors: elliott da. Urology. 2024 Feb;184:135-141. doi: 10.1016/j.urology.2023.10.018. Epub 2023 Nov 10. Urology. 2024. PMID: 37951360

2

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system.

Herr DJ, Elliott DA, Duchesne G, Stensland KD, Caram MEV, Chapman C, Burns JA, Hollenbeck BK, Sparks JB, Shin C, Zaslavsky A, Tsodikov A, Skolarus TA. Herr DJ, et al. Among authors: elliott da. Cancer. 2023 Oct 15;129(20):3326-3333. doi: 10.1002/cncr.34916. Epub 2023 Jun 30. Cancer. 2023. PMID: 37389814

3

Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.

Gharzai LA, Jiang R, Wallington D, Jones G, Birer S, Jairath N, Jaworski EM, McFarlane MR, Mahal BA, Nguyen PL, Sandler H, Morgan TM, Reichert ZR, Alumkal JJ, Mehra R, Kishan AU, Fizazi K, Halabi S, Schaeffer EM, Feng FY, Elliott D, Dess RT, Jackson WC, Schipper MJ, Spratt DE. Gharzai LA, et al. Lancet Oncol. 2021 Mar;22(3):402-410. doi: 10.1016/S1470-2045(20)30730-0. Lancet Oncol. 2021. PMID: 33662287 Free PMC article.

4

Cannabis Use in Patients Seen in an Academic Radiation Oncology Department.

Cousins MM, Mayo C, Devasia T, Dykstra M, Regan S, Miller S, Allen SG, Bryant AK, Morales-Rivera K, Herr DJ, Edwards DM, Takayesu J, Birer S, Egerer N, Evans J, Elliott D, Henderson C, Laucis AM, McFarlane M, Dragovic AF, Shah J, Hayman JA, Coughlin LN, Ilgen M, Jagsi R. Cousins MM, et al. Pract Radiat Oncol. 2023 Mar-Apr;13(2):112-121. doi: 10.1016/j.prro.2022.11.002. Epub 2022 Nov 30. Pract Radiat Oncol. 2023. PMID: 36460181 Free PMC article.

5

[No title available]

[No authors listed] [No authors listed] PMID: 37785290

6

Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.

Sankar K, Bryant AK, Strohbehn GW, Zhao L, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. Sankar K, et al. Cancers (Basel). 2022 Jan 26;14(3):614. doi: 10.3390/cancers14030614. Cancers (Basel). 2022. PMID: 35158881 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 37785836

8

Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer.

Edwards DM, Sankar K, Alseri A, Jiang R, Schipper M, Miller S, Dess K, Strohbehn GW, Elliott DA, Moghanaki D, Ramnath N, Green MD, Bryant AK. Edwards DM, et al. Among authors: elliott da. Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):963-970. doi: 10.1016/j.ijrobp.2023.09.050. Epub 2023 Oct 2. Int J Radiat Oncol Biol Phys. 2024. PMID: 37793573

9

Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer.

Bryant AK, Sankar K, Strohbehn GW, Zhao L, Elliott D, Daniel V, Ramnath N, Green MD. Bryant AK, et al. Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):60-65. doi: 10.1016/j.ijrobp.2021.12.176. Epub 2022 Feb 1. Int J Radiat Oncol Biol Phys. 2022. PMID: 35115216 Free PMC article.

10

Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab.

Bryant AK, Sankar K, Strohbehn GW, Zhao L, Daniel V, Elliott D, Ramnath N, Green MD. Bryant AK, et al. Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):752-758. doi: 10.1016/j.ijrobp.2022.03.015. Epub 2022 Apr 19. Int J Radiat Oncol Biol Phys. 2022. PMID: 35450753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page